Abeona Therapeutics Inc.ABEONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+55.6%
5Y CAGR+22.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+55.6%/yr
vs -3.7%/yr prior
5Y CAGR
+22.3%/yr
Recent acceleration
Acceleration
+59.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$65.03M+117.9%
2024$29.85M+57.1%
2023$19.00M+10.1%
2022$17.26M-20.3%
2021$21.64M-9.0%
2020$23.78M+14.8%
2019$20.70M+3.0%
2018$20.11M+83.7%
2017$10.94M-17.7%
2016$13.29M-